erythrosine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, NP; Moochhala, SM; Sato, T; Shahi, GS; Sunamoto, J | 1 |
| Brittebo, EB; Fredriksson, A; Ostergren, A | 1 |
| Andersen, JK; Cherny, RA; Chinta, S; Di Monte, D; Kaur, D; Kumar, J; Rajagopalan, S | 1 |
| Bian, GL; Cao, R; Chen, LW; Shi, M; Wang, YQ; Wei, LC | 1 |
| Deutch, AY; Garcia, BG; Neely, MD | 1 |
| Gu, Q; Lu, E; Paule, MG; Raymick, J; Sarkar, S | 1 |
6 other study(ies) available for erythrosine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its toxic metabolites on the physicochemical property of the liposomal membrane in relation to their cytochrome P-450 inhibition.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Dimyristoylphosphatidylcholine; Fluoresceins; Fluorescent Dyes; Kinetics; Liposomes; Male; Membrane Fluidity; Mice; Mice, Inbred C57BL; Microsomes, Liver; Oxidoreductases; Pyridinium Compounds; Spectrometry, Fluorescence | 1992 |
Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Carbolines; Caspase 3; Caspases; Disease Models, Animal; Fluoresceins; Gait Disorders, Neurologic; Glial Fibrillary Acidic Protein; Gliosis; Harmine; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; Nerve Degeneration; Neuroglia; Neurons; Neurotoxins; Organic Chemicals; Parkinsonian Disorders; PC12 Cells; Rats; Substantia Nigra | 2006 |
Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Age Factors; Aging; Animals; Dopamine; Exploratory Behavior; Ferritins; Fluoresceins; Gene Expression; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Nerve Degeneration; Neurons; Organic Chemicals; Silver Staining; Substantia Nigra; Tyrosine 3-Monooxygenase | 2007 |
Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Fluoresceins; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Neurotoxins; Organic Chemicals; Substantia Nigra; Tyrosine 3-Monooxygenase | 2007 |
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cerebral Cortex; Corpus Striatum; Dendrites; Disease Models, Animal; Dopamine; Excitatory Amino Acid Agents; Fluoresceins; Glutamic Acid; Male; Neurons; Organ Culture Techniques; Organic Chemicals; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Silver Staining | 2010 |
Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; bcl-2-Associated X Protein; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Extracellular Signal-Regulated MAP Kinases; Fluoresceins; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myeloid Cell Leukemia Sequence 1 Protein; Neurotoxins; Tyrosine 3-Monooxygenase | 2018 |